Fortis Healthcare Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 24,33,292 shares,. Its Average Traded Price (ATP) is ₹847.12, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹837.85.
Fortis Healthcare has an upper circuit limit of ₹965.05 and a lower circuit limit of ₹789.65. The total value traded stands at ₹206.13 CR, and the delivery percentage for the day is 55.45%.
The stock is currently traded with a market lot size of 1. Fortis Healthcare also offers a dividend yield of 0.11%.
Fortis Healthcare Share Price Chart
Fortis Healthcare Share Key Metrics
Volume
24.33 L
Market Cap
63254.17 CR
LTQ@LTP
2@837.85
ATP
847.12
Var Margin
13.94 %
Circuit Range
789.65-965.05
Delivery %
55.45 %
Value
206.13 CR
ASM/GSM
No
Market Lot
1
Fortis Healthcare Resistance and Support
Pivot 883.95
Resistance
First Resistance
890.55
Second Resistance
903.75
Third Resistance
910.35
Support
First Support
870.75
Second Support
864.15
Third Support
850.95
Fortis Healthcare Futures & Options
837.85
-39.5 (-4.5%)
Fortis Healthcare Option Chain
View Price, OI, Greeks & More...
29SEP26
837.85
-43.40 (4.92%)
27OCT26
844.00
-41.20 (4.65%)
23NOV26
849.20
-41.60 (4.67%)
FORTIS|29SEP26 CE 830.00
13.65
-32.1 (-70.16%)
FORTIS|29SEP26 PE 840.00
8.75
8.25 (1650%)
Fortis Healthcare Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Fortis Healthcare Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-06 | Quarterly Results |
| 2026-05-22 | Audited Results & Final Dividend |
| 2026-02-13 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-06 | Quarterly Results & Others |
| 2025-05-20 | Audited Results & Final Dividend |
| 2025-02-07 | Quarterly Results |
| 2024-11-08 | Quarterly Results |
| 2024-10-09 | Others |
| 2024-08-30 | To consider Fund Raising |
| 2024-08-06 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-07-24 | 2026-07-24 | View More |
Fortis Healthcare News
Fortis Healthcare Ltd - 532843 - Update On Material Litigation Filed By Northern TK Venture Pte Ltd. (''NTK''), The Promoter Shareholder Of The Company, Against Daiichi Sankyo Company, Limited Before The Tokyo District Court In Japan
Fortis Healthcare's promoter NTK has appealed a Tokyo District Court judgment, continuing material litigation. Separately, IHH Healthcare, the parent company, confirmed plans to increase its stake in Fortis to 51% and expand bed capacity to 10,000 by 2031, showcasing long-term commitment.
Sep 25 2026 13:40:37
Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Fortis Healthcare's subsidiary, FHTL, signed definitive agreements to provide healthcare services to a new 400+ bed super specialty hospital in Ashok Vihar, Delhi. FHTL will also provide a Rs. 567 crore loan for the hospital's construction and operation over 3-4 years.
Sep 16 2026 19:05:08
Fortis Healthcare Ltd - 532843 - Intimation For Signing The Definitive Agreements By Fortis Hospotel Limited (Wholly Owned Subsidiary Of The Company) To Provide Healthcare Services To A 400+ Bedded Super Specialty Hospital In Ashok Vihar, New Delhi
Fortis Healthcare's subsidiary, Fortis Hospotel, has entered into definitive agreements with SLJ Society to provide services for a 400+ bed super specialty hospital in Ashok Vihar, New Delhi. This includes a Rs. 567 crore loan for the hospital's construction and a 29-year healthcare services agreement.
Sep 16 2026 19:02:43
Fortis Healthcare Ltd - 532843 - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015 About Filing Of Special Leave Petition ('SLP') Before The Hon'Ble Supreme Court Of India
Fortis Healthcare has filed a Special Leave Petition (SLP) before the Supreme Court of India. This action challenges a Delhi High Court judgment dated August 31, 2026, pertaining to the ongoing Daiichi Sankyo legal dispute.
Sep 16 2026 11:01:41
Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Fortis Healthcare is scheduled to hold two in-person investor/analyst meetings on September 21 and 22, 2026. These meetings, organized by BNP Paribas and J.P. Morgan, will be held in Mumbai to discuss general business updates.
Sep 15 2026 18:53:19
Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Fortis Healthcare is scheduled to hold two in-person investor/analyst meetings on September 21 and 22, 2026. These meetings, organized by BNP Paribas and J.P. Morgan, will be held in Mumbai to discuss general business updates.
Sep 15 2026 18:20:50
Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Fortis Healthcare will conduct an investor/analyst meet (Non-Deal Roadshow) in London on September 14-15, 2026. This in-person group meet, organized by Jefferies, will cover general business and industry updates.
Sep 09 2026 23:43:26
Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Fortis Healthcare has made the audio recording of its Investors/Analysts Meet, held on September 4, 2026, available on its website. The meet discussed recent developments, providing investors with access to the full discussion.
Sep 04 2026 17:27:15
Fortis Healthcare Ltd - 532843 - Announcement Under Regulation 30 (LODR) - Regarding Order Passed By The Hon'Ble Delhi High Court In Relation To Certain Applications Filed By Daiichi Sankyo Company, Limited Inter Alia The Company. Detailed Disclosure Is Attached.
Fortis Healthcare announced the Delhi High Court ordered a forensic audit on August 31, 2026. The audit will investigate the dissipation of former promoters' shareholding and the change in company control. The company stated no liability or penalty was imposed on it.
Sep 01 2026 00:34:58
Fortis Healthcare Management
| Name | Position |
|---|---|
| Satyendra Chauhan | Company Secretary & Compliance Officer |
| Leo Puri | Chairman |
Fortis Healthcare Similar Stocks
Dr. Reddy's Laboratories Ltd.
1201.00
0.60 (0.05%)
Manipal Health Enterprises Ltd.
727.50
-15.00 (2.02%)
Aurobindo Pharma Ltd.
1712.00
-4.00 (0.23%)
Lupin Ltd.
2092.00
-8.70 (0.41%)
Glenmark Pharmaceuticals Ltd.
2380.00
-50.40 (2.07%)
Aster DM Quality Care Ltd.
759.40
-9.25 (1.20%)
Alkem Laboratories Ltd.
5274.00
-52.00 (0.98%)
Biocon Ltd.
382.15
-4.85 (1.25%)
Abbott India Ltd.
26955.00
95.00 (0.35%)
Ipca Laboratories Ltd.
1970.80
-26.30 (1.32%)
Fortis Healthcare FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in FORTIS
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
+ Free 1st Year AMC
Or Download Choice FinX App
Daily Research Calls
₹0 AMC for First Year
Dedicated RM Support
+ Free 1st Year AMC